Dupilumab Approved for Chronic Spontaneous Urticaria

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in patients ages 12 and older with CSU.
Medscape Medical News